Abstract:15% of cases) but often serious and condition the prognosis [1,4].The most frequent of these disorders including pulmonary, renal, neurological, and digestive [1,4]. These systemic manifestations are very polymorphic, heterogeneous, and non-specific, justifying the qualification of this syndrome as a "great masquerader" [5]. The specific neurological involvement of this disease (neuro-Sjögren) is not uncommon but very polymorphic and often under-diagnosed [3,6]. Depression, classified among the manifestations … Show more
“…The difference between this case and Salem Bouomrani et al [ 8 ] case is our patient's younger age and difference in clinical manifestations. As Bouomrani's patient presented depressive symptoms and did not respond to antidepressants while improving on Methylprednisolone pulse treatment followed by 1 mg/kg oral prednisolone.…”
Section: Discussioncontrasting
confidence: 64%
“…Depression, anxiety, psychiatric features, and cognitive impairment are usually the most frequent [ 5 , 6 ]. However, the association with bipolar disorder seems rare and not frequently documented [ 7 , 8 ].…”
“…The difference between this case and Salem Bouomrani et al [ 8 ] case is our patient's younger age and difference in clinical manifestations. As Bouomrani's patient presented depressive symptoms and did not respond to antidepressants while improving on Methylprednisolone pulse treatment followed by 1 mg/kg oral prednisolone.…”
Section: Discussioncontrasting
confidence: 64%
“…Depression, anxiety, psychiatric features, and cognitive impairment are usually the most frequent [ 5 , 6 ]. However, the association with bipolar disorder seems rare and not frequently documented [ 7 , 8 ].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.